Differential effect of the p53 inducers Nutlin-3 and RITA on cell lines with different p53 status

被引：0
|
作者：
Weilbacher, A. [1 ,2 ]
Gutekunst, M. [1 ,2 ]
Oren, M. [3 ]
Aulitzky, W. [4 ]
van der Kuip, H. [1 ,2 ]
机构：
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany
[2] Univ Tubingen, Stuttgart, Germany
[3] Weizmann Inst Sci, Dept Mol Biol, IL-76100 Rehovot, Israel
[4] Robert Bosch Hosp Stuttgart, Dept Internal Med 2, Stuttgart, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：195 / 196
页数：2
相关论文
共 50 条
  • [1] Nutlin-3 radiosensitizes prostate cancer cell lines independent of p53 status
    Supiot, S.
    Hill, R.
    Bristow, R.
    EJC SUPPLEMENTS, 2006, 4 (12): : 163 - 164
  • [2] The MDM2 Inhibitor Nutlin-3 But Not the p53 Activator RITA Induces Loss-of-function p53 Mutations
    Michaelis, M.
    Rothweiler, F.
    Barth, S.
    Cinatl, J.
    van Rikxoort, M.
    von Deimling, A.
    Roedel, F.
    Speidel, D.
    Cinatl, J., Jr.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 43 - 43
  • [3] Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3
    M H Aziz
    H Shen
    C G Maki
    Oncogene, 2011, 30 : 4678 - 4686
  • [4] Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3
    Aziz, M. H.
    Shen, H.
    Maki, C. G.
    ONCOGENE, 2011, 30 (46) : 4678 - 4686
  • [5] Awakening p53 in senescent cells using nutlin-3
    Schug, Thaddeus T.
    AGING-US, 2009, 1 (10): : 842 - 844
  • [6] Inability of p53-reactivating compounds Nutlin-3 and RITA to overcome p53 resistance in tumor cells deficient in p53Ser46 phosphorylation
    Ma, Teng
    Yamada, Shumpei
    Ichwan, Solachuddin J. A.
    Iseki, Sachiko
    Ohtani, Kiyoshi
    Otsu, Megumi
    Ikeda, Masa-Aki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 417 (03) : 931 - 937
  • [7] A Stapled p53 Helix Targets HDMX to Overcome Nutlin-3 Resistance and Reactivate the p53 Tumor Suppressor Pathway in Cancer
    Bernal, Federico
    Wade, Mark
    Silverstein, Amy M.
    Verdine, Gregory L.
    Wahl, Geoffrey M.
    Walensky, Loren D.
    BLOOD, 2008, 112 (11) : 915 - 915
  • [8] Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53
    Supiot, Stephane
    Hill, Richard P.
    Bristow, Robert G.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (04) : 993 - 999
  • [9] p53 mutations induced by the MDM2 inhibitor nutlin-3 in p53 wild-type neuroblastoma cells
    Michaelis, M.
    Wass, M.
    Cinatl, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S72 - S72
  • [10] PHARMACOLOGIC ACTIVATION OF THE P53 PATHWAY BY NUTLIN-3 INHIBITS MEDULLOBLASTOMA CELL PROLIFERATION IN VITRO
    Kuenkele, Annette
    de Preter, Katleen
    Vandesompele, Jo
    Pajtler, Kristian
    Heukamp, Lukas
    Grotzer, Michael
    Schramm, Alexander
    Eggert, Angelika
    Schulte, Johannes
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 918 - 918
12345